Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
81 studies found for:    vaccine niaid | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in Thailand
Condition: Dengue
Interventions: Biological: TV003;   Biological: Placebo for TV003
2 Recruiting Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products
Condition: Healthy Volunteers
Intervention:
3 Recruiting Volunteer Screening for Vaccine and Antivirals Clinical Trials
Condition: Healthy Volunteer
Intervention:
4 Recruiting Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers
Conditions: Healthy Volunteer;   HIV Vaccine
Interventions: Biological: Ad4-mgag;   Biological: Ad4-EnvC150
5 Recruiting VRC 320: A Phase I, Randomized Clinical Trial to Evaluate the Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA090-00-VP, Administered Via Needle and Syringe or Needle-free Injector, PharmaJet, inHealthy Adults
Conditions: Prevention of Zika Infection;   Zika-Specific Immune Response
Intervention: Biological: VRC-ZKADNA090-00-VP
6 Recruiting Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults
Condition: Respiratory Syncytial Virus
Intervention: Biological: VRC-RSVRGP084-00VP
7 Recruiting Study in Healthy Volunteers to Evaluate the Safety and Immunogenicity of AGS-v, a Universal Mosquito-Borne Disease Vaccine
Condition: Mosquito-Borne Disease
Interventions: Biological: AGS-v;   Biological: AGS-v + adjuvant;   Other: Placebo
8 Recruiting Screening Volunteers for Clinical Trials
Condition: Human Health
Intervention:
9 Recruiting Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome
Condition: Autosomal-dominant Hyper-IgE Syndrome
Intervention: Drug: NDV-3A
10 Recruiting Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali
Condition: Malaria
Interventions: Biological: Pfs25M-EPA/AS01;   Biological: Pfs230D1M-EPA/AS01;   Other: AS01;   Biological: Bexsero (Comparator Vaccine);   Biological: Fluarix;   Other: Normal Saline;   Drug: Coartem
11 Recruiting Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates
Condition: Malaria
Intervention:
12 Recruiting Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge
Condition: Malaria
Intervention:
13 Recruiting PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response
Condition: Ebola Virus Disease
Intervention:
14 Recruiting Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies
Condition: Blood Component Removal
Intervention:
15 Recruiting Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants and Children 6 to 24 Months of Age
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV D46/NS2/N/ΔM2-2-HindIII Vaccine;   Biological: Placebo
16 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine;   Biological: Placebo (1x Leibovitz L-15 medium)
17 Recruiting ZIKA Vaccine in Naive Subjects
Condition: Zika Virus Infection
Interventions: Drug: Saline;   Biological: Zika Virus Purified Inactivated Vaccine (ZPIV)
18 Recruiting Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers
Condition: Influenza
Intervention: Biological: Influenza Virus Vaccine Inactivated
19 Recruiting Analysis of Bone Marrow and Blood B Cell Immune Responses to Influenza Vaccination
Condition: Influenza
Intervention: Biological: Influenza Virus Vaccine Inactivated
20 Recruiting A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
Condition: Avian Influenza
Interventions: Biological: Influenza Virus Vaccine, Live Attenuated H7N9 Anhui 2013/AA ca;   Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013;   Drug: MF59 adjuvant

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.